Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
3.130
+0.170 (5.74%)
At close: Feb 18, 2026, 4:00 PM EST
3.100
-0.030 (-0.96%)
After-hours: Feb 18, 2026, 7:46 PM EST

Cabaletta Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
301111973270107300
Market Cap Growth
157.93%-88.59%260.85%151.03%-64.23%-10.59%
Enterprise Value
167-57813184-12183
Last Close Price
3.132.2722.709.253.7912.48
PB Ratio
2.160.734.122.580.912.74
P/TBV Ratio
2.160.734.122.580.912.74
Debt / Equity Ratio
0.190.100.020.05--
Net Debt / Equity Ratio
-0.96-0.97-1.00-0.97-1.04-0.99
Net Debt / EBITDA Ratio
0.831.203.231.922.683.25
Net Debt / FCF Ratio
1.121.644.362.083.473.97
Quick Ratio
3.506.0515.0811.2314.5920.98
Current Ratio
3.606.1515.2911.4714.8621.92
Return on Equity (ROE)
-101.06%-59.64%-39.73%-47.62%-40.69%-26.90%
Return on Assets (ROA)
-51.82%-35.66%-25.18%-27.81%-24.02%-16.51%
Return on Capital Employed (ROCE)
-113.50%-79.20%-31.40%-50.40%-39.30%-30.90%
Earnings Yield
-52.61%-104.43%-6.96%-19.65%-43.11%-11.11%
FCF Yield
-39.91%-81.51%-5.58%-18.12%-32.85%-9.13%
Buyback Yield / Dilution
-36.24%-19.77%-39.54%-14.01%-11.20%-323.18%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q